We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ELEKTA

Elekta develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well a... read more Featured Products: More products

Download Mobile App




Studies Confirm Effectiveness of Stereotactic Neurosurgery

By HospiMedica International staff writers
Posted on 02 May 2017
New studies have confirmed the clinical effectiveness of a minimally invasive stereotactic neurosurgery system used to treat brain cancer, other non-cancerous brain tumors, and neurological conditions in patients.

The medical imaging systems provider also showcased a new stereotactic neurosurgery system intended for target localization, and coordinate referencing in precision neurosurgery.

The Leksell Gamma Knife developed by Elekta was featured in more than 15 scientific presentations at the annual meeting of the American Association of Neurological Surgeons (AANS) in Los Angeles, California, in the US, in April 2017. More...
The head frame of the new Leksell Vantage Stereotactic system is made from a novel epoxy composite material designed to improve the speed, imaging quality, and patient comfort during neurosurgery procedures.

The new Leksell Vantage system is pending 510(k) clearance by US Food and Drug Administration, but received CE (Conformité Européenne) Mark clearance in March 2017, and will now be put into clinical practice in Europe for the first time in hospitals in France, the Netherlands, the UK, and Sweden.

VP of the Neuroscience portfolio at Elekta, Jesper Söderqvist, said, "Our Leksell Stereotactic System has been helping clinicians achieve outstanding patient outcomes for more than 60 years, and Vantage improves upon this gold standard platform to deliver uncompromising accuracy in stereotactic imaging and treatment. With potential for faster imaging, more efficient workflow, reduced artifacts and a better overall user experience, Leksell Vantage is a welcome advancement for physicians and their patients."


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Gas Analyzer
i-Check200
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.